Foundations Investment Advisors LLC purchased a new stake in Clover Health Investments, Corp. (NASDAQ:CLOV – Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 19,547 shares of the company’s stock, valued at approximately $55,000.
Several other hedge funds and other institutional investors have also recently made changes to their positions in the stock. Jupiter Asset Management Ltd. grew its holdings in Clover Health Investments by 18.1% in the 1st quarter. Jupiter Asset Management Ltd. now owns 4,525,079 shares of the company’s stock valued at $3,593,000 after buying an additional 692,878 shares in the last quarter. XTX Topco Ltd purchased a new position in shares of Clover Health Investments during the 2nd quarter worth $932,000. AQR Capital Management LLC boosted its position in shares of Clover Health Investments by 4.6% during the 2nd quarter. AQR Capital Management LLC now owns 729,706 shares of the company’s stock valued at $898,000 after acquiring an additional 32,288 shares during the last quarter. Choreo LLC purchased a new stake in shares of Clover Health Investments in the second quarter valued at about $344,000. Finally, Bayesian Capital Management LP acquired a new stake in Clover Health Investments during the first quarter worth about $142,000. Institutional investors and hedge funds own 19.77% of the company’s stock.
Clover Health Investments Stock Performance
CLOV opened at $3.92 on Monday. The stock has a market capitalization of $1.95 billion, a PE ratio of -14.52 and a beta of 2.13. Clover Health Investments, Corp. has a one year low of $0.61 and a one year high of $4.71. The business’s 50 day moving average price is $3.29 and its 200 day moving average price is $1.95.
Wall Street Analysts Forecast Growth
Separately, UBS Group initiated coverage on shares of Clover Health Investments in a report on Monday, October 7th. They issued a “neutral” rating and a $4.00 target price on the stock.
Get Our Latest Analysis on Clover Health Investments
About Clover Health Investments
Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.
Featured Stories
- Five stocks we like better than Clover Health Investments
- What Makes a Stock a Good Dividend Stock?
- Real Estate Sector Outperforms: 3 Stocks to Gain Exposure
- Comparing and Trading High PE Ratio Stocks
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
Want to see what other hedge funds are holding CLOV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clover Health Investments, Corp. (NASDAQ:CLOV – Free Report).
Receive News & Ratings for Clover Health Investments Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clover Health Investments and related companies with MarketBeat.com's FREE daily email newsletter.